CytoSorbents Regains Compliance With Nasdaq Minimum Bid Price Requirement
CytoSorbents (CTSO) announced on September 22, 2026 that it has regained compliance with the minimum bid price requirement set by the Nasdaq Stock Market. The company had previously been notified of its non-compliance but took corrective actions to meet the listing standards. Regaining compliance is a positive development for CytoSorbents as it avoids potential delisting and maintains its presence on the Nasdaq, which can support investor confidence and market access.
Topics: Nasdaq requirements stock compliance